Treatment approaches to major depressive disorder relapse - Part 2: Reinitiation of antidepressant treatment

Psychotherapy and Psychosomatics

Volumn 71, Issue 4, 2002, Pages 195-199

  Fava, Maurizio ^a   Schmidt, Mark E ^b   Zhang, Shuyu ^b   Gonzales, Jill ^b   Raute, Nancy J ^b   Judge, Rajinder ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Depression; Enteric coated fluoxetine; Long term; Relapse

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; ENTERIC COATED TABLET; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROBABILITY; RELAPSE; SCORING SYSTEM; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; SEROTONIN UPTAKE INHIBITORS;

EID: 0036311872     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063644     Document Type: Article

References (21)

1. Treatment of major depression
2. Pharmacotherapy of depressive disorders: A consensus statement
3. Practice guidelines for major depressive disorder in adults
4. Selective contracting and patient outcomes: A case study of formulary restrictions for selective serotonin reuptake inhibitor antidepressants
5. Effect of antidepressant therapy on health care utilization and costs in primary care
6. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants
7. Longitudinal patterns of antidepressant prescribing in primary care in the UK: Comparison with treatment guidelines
8. Lithium-discontinuation-induced refractoriness: Preliminary observations
9. Retreatment for relapse following desipramine discontinuation in dysthymia
10. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo
11. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder
12. Treatment of imipramine-resistant recurrent depression. 3. Efficacy of monamine oxidase inhibitors
13. Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment
14. Differential responses to a single antidepressant in recurrent episodes of major depression
15. Holding on: Depression, sensitization by antidepressant drugs, and the prodigal experts
16. Management of nonresponse and intolerance: Switching strategies
17. New approaches to the treatment of refractory depression
18. Reducing relapse in depressed outpatients with atypical features: A pilot study
19. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression
20. Management of major depression in the primary care setting